Skip to Main Content

Paper Details

Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?
Haematologica
0
2023
Author NameAffiliation
Farhad RavandiThe University of Texas, MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2